logo
Meet Kerala's Pranav S, recipient of Australian National University's FRT programme

Meet Kerala's Pranav S, recipient of Australian National University's FRT programme

Indian Express4 days ago
'I had a dream to visit a foreign country for higher education, but I did not think that the opportunity would come this early,' said Pranav S, a native of Kerala's Kollam, and one of the shortlisted students for the Future Research Talent (FRT) programme. The programme is jointly awarded by the Australian National University (ANU) College of Science and Medicine, the ANU College of Systems and Society, and the ANU College of Law, Governance and Policy to students. Every year, 46 students from selected Indian institutions are shortlisted based on their pitch.
Pranav, who is among 45 other students, is working on a project titled 'Early childhood shocks and their impact on older age health outcomes' under the supervision of Dr My Tran and Dr Jinhu Li, in the National Centre for Epidemiology and Population Health at ANU. Under the programme, students get approximately 2.5 to 3 months or 10-12 weeks at ANU to collaborate on a research project, and the value of each FRT award is A$8,500, which is approximately Rs 4,77,490.
Pranav is a five-year Integrated course student in Economics at the University of Hyderabad (UoH), and was not aware of the FRT programme; however, a mail from the University changed his career trajectory.
'I wasn't initially aware of the programme, but after doing some research, I decided to give it a try. In the first round, the University invited project pitches. The biggest challenge I faced was identifying a project that aligned with my area of interest. At that crucial point, I turned to some friends, seniors, and especially my mentor from the Economics department, Professor G. Sridevi, for guidance,' he said.
To help future aspirants, Pranav outlined the application and selection process for the FRT programme. Applications open every December, and students are shortlisted based on their research pitches, which are reviewed by ANU. The first round is conducted in collaboration with partner institutions, which nominate candidates for specific projects through an internal selection process.
'The FRT scholarship primarily considers academic merit and prior research experience. Applicants must submit a CV and a Statement of Purpose (SOP), both of which play a crucial role in the evaluation. You can select up to three preferred projects from the list of available options. The FRT team then evaluates the profiles, consults with project supervisors, and finalises the selection based on their rankings,' Pranav explained.
'Visiting Australia was my first international trip and I was quite nervous about how things would be managed,' he said. He told indianexpress.com, that the ANU team made them comfortable. Before visiting the country, they did some email interactions to know each other and for documentation for the visa, as they are in the country under the Temporary Research Activity 408 SubClass Visa.
'People at ANU are super systematic in their approach. They have clear thoughts and ideas. So, when we reached the University, they spoke at length about the departments and people. My supervisors were also really supportive, they also knew that like I was coming for the first time in a foreign country, so they tried to assist me in every possible way,' he added.
Without a hurry to start the programme, they gave time to the Indian students to settle and get to know their office spaces. 'The people in the space are supportive and full of positive vibes. They help you with the project and make sure you are comfortable,' said Pranav S, whose mother works as an accountant in a private firm in Kerala.
Sharing about his day as an FRT researcher at the Australian National University, Pranav claimed that the work culture in the University is balanced.
'A researcher isn't required to be present in the department every day unless the project specifically demands it. In my case, the department provided a wonderful office space, which allows me to work more efficiently. So, I come in from Monday to Friday, usually from 9:30 AM to 5:00 PM, with regular breaks. The emphasis here is on what we gain from new academic exposures,' said the student, who scored 95.6 per cent in the Class 12 CBSE examinations.
When asked about his project's objective, he shared that his research explores the intersection between Economics and public health aspects. Through this research, the team aim to find the existing gaps in the study of early childhood shocks and measuring its impact on the healthy ageing population. The study is conducted concerning the Indian population.
During his initial stay at ANU, he got the opportunity to meet and interact with Indian High Commissioner Gopal Baglay and Professor Chenupati Jagadish.
Sheen Kachroo is the Senior Sub-Editor working with the Indian Express Digital. ... Read More
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Birth issues for Panchkula's Mother & Childcare Hospital even after first birthday
Birth issues for Panchkula's Mother & Childcare Hospital even after first birthday

Time of India

time21 minutes ago

  • Time of India

Birth issues for Panchkula's Mother & Childcare Hospital even after first birthday

1 2 Panchkula: One year after its virtual inauguration by Haryana chief minister Nayab Singh Saini, the towering 11-storey Mother and Childcare Hospital in Panchkula stands tall — mostly as a monument to missed deadlines and unrealized promises. While the building boasts a Rs 113-crore price tag and a skyline-worthy silhouette, its actual contribution to healthcare remains limited to two OPDs. Yes, just two. The rest of the facility — labour rooms, operation theatres, ICUs, emergency wings, and even the education institute — are still waiting for their debut. The OPDs finally opened in March, after a long delay and a wave of negative press. But even four months later, the promised gradual transition of other departments remains a distant dream. Apparently, the hospital is still in its "soft launch" phase — except no one's quite sure when the "hard launch" will happen. The culprit? A missing fire NOC. Turns out, you can build a hospital, paint it, and even inaugurate it, but without a fire safety clearance, you can't actually use it. The OPDs were allowed to function only after provisional NOCs were hurriedly issued — because nothing says "urgent healthcare" like a bureaucratic scramble triggered by bad publicity. A fire wing official reminded everyone that this isn't just any building — it's meant for women and children. So, no, they won't be cutting corners. The hospital still hasn't addressed the fire safety anomalies flagged months ago. Thus, only OPDs were given a go-ahead with a provisional NOC, the fire official added. Dr R S Chauhan, principal medical officer (PMO), Panchkula, said, "We are not in a hurry as the public works department (PWD) is still carrying out the works. We highlighted our requirements, which are currently being undertaken. Following this, the fire NOC will be applied for and procured again." Importantly, the adjoining civil hospital — meant to be relieved by this new facility — is bursting at the seams. With 300 sanctioned beds and 500 patients, maternity wards have become a game of musical chairs, except with beds. Two women to a bed? Why not — it's bonding time! Ultrasounds and tests? Bring snacks, it's going to be a long wait. The new hospital was supposed to add 200 beds—100 for gynaecology and 100 for paediatrics—bringing the total to 500. But for now, those beds are just numbers on a blueprint. The building, with its 7 hospital floors and 3 parking levels, is more of a vertical promise than a functioning healthcare facility.

Letters to The Editor — July 17, 2025
Letters to The Editor — July 17, 2025

The Hindu

time2 hours ago

  • The Hindu

Letters to The Editor — July 17, 2025

Indian nurse's case The case of the Indian nurse, Nimisha Priya, in Yemen, and a reprieve for her, is a reflection of the delicate blend of justice, mercy, faith, and diplomacy. It shows that even in the shadow of death, life can still be reclaimed through compassion and timely action (Front page, July 16). Mohammad Asad, Mumbai Unhealthy food intake While steps are being initiated through quality checks and spreading awareness on the health risks associated with the consumption of snacks and sugar intake (Editorial, 'More than symbolic', July 16), one wonders whether these steps are adequate. The directions on labelling alone may not suffice. Most packages already have information on the percentages of oil, sugar and trans-fat content. The real dangers lie elsewhere. The consumption of a variety of snacks prepared and sold by street and roadside vendors is on the rise, but is there a watch being kept on the cheap quality ingredients that are being used in the preparation? There is nothing more profitable today than the food business. There are no checks in place especially on the use of cooking oils and the ingredients. There needs to be a system where quality checks are mandatory. Comprehensive and meticulous planning is needed. But, most importantly, its execution is a must. Balasubramaniam Pavani, Secunderabad Danger and drills A goods train carrying 27,000 litres of diesel caught fire near Tiruvallur station, which is close to Chennai, on July 13. The blaze forced the cancellation of a number of train services and the evacuation of people who lived nearby. Although firefighters managed to control the fire, this is an incident that has exposed gaps in safety protocols, equipment checks and communication. Southern Railway must conduct regular emergency drills. Being proactive measures will safeguard lives and property, and restore public trust. Vivek M. Jain, Chennai

Glenmark Pharmaceuticals targets 70% branded portfolio by 2030, boosts focus on novel drugs
Glenmark Pharmaceuticals targets 70% branded portfolio by 2030, boosts focus on novel drugs

Time of India

time2 hours ago

  • Time of India

Glenmark Pharmaceuticals targets 70% branded portfolio by 2030, boosts focus on novel drugs

Glenmark Pharmaceuticals is pivoting to a sharper, innovation-driven company over the next 4-5 years with focus on its novel drug portfolio and strengthening its branded business, managing director Glenn Saldanha said. Glenmark 3.0 will look at bulking up its branded portfolio to 70% by 2030 from the current 60% with focus on three of its key therapeutic areas where the company is putting all its muscle to scale, he said at an investor's day meet in Mumbai. "2030 and onwards we see ourselves as a leading global innovation-driven company with leadership in three therapeutic areas that is dermatology, respiratory and oncology ," said Saldanha. "We are a $1.6 billion organisation and last year, 60% of our revenue came from branded products." Explore courses from Top Institutes in Select a Course Category Data Science Operations Management Cybersecurity Product Management Digital Marketing Public Policy Degree Technology PGDM Others MBA Management healthcare Finance Artificial Intelligence Healthcare Design Thinking others Project Management CXO Data Science Data Analytics Leadership MCA Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK DABS India Starts on undefined Get Details Skills you'll gain: Duration: 30 Weeks IIM Kozhikode SEPO - IIMK-AI for Senior Executives India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months E&ICT Academy, Indian Institute of Technology Guwahati CERT-IITG Postgraduate Cert in AI and ML India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months E&ICT Academy, Indian Institute of Technology Guwahati CERT-IITG Prof Cert in DS & BA with GenAI India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIT Madras CERT-IITM Advanced Cert Prog in AI and ML India Starts on undefined Get Details The roadmap for the next 4-5 years includes increasing contribution from high-growth EU and EM markets, growing the US generic business via respiratory, injectables product launches and growing a robust pipeline of innovative multi-specifics ( novel drugs to treat cancers) through Ichnos Glenmark Innovation (IGI). IGI last week entered a landmark pact with US-based AbbVie to develop and commercialise its innovative drug ISB 2001 used for the treatment of multiple myeloma, a rare form of blood cancer. It will get an upfront payment of $700 million (about Rs 6,000 crore) from AbbVie, in addition to potential milestone-linked payments of $1.2 billion. "We are looking at leveraging the platform and expanding on that further to continue to add more value," he said. Live Events Company executives said in territories where Glenmark gets the commercial rights of ISB 2001 the market opportunity will be $5 billion. "3.0 is all about moving up the value chain to become an innovation-led company with a large commercial footprint and transforming into something global," said Saldanha, seeking to differentiate the organisation from its domestic peers. "The second part of it is to create long-term sustainable value for all our stakeholders and ensure great return ratios." "The next 10 years are going to be about trying to create something transformational, focus on moving up the value chain, launch branded products and doing this in a fiscally disciplined manner where we have good margins and returns," he said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store